-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RHdSpGuZvImvIxW6HzETn0DvuRNG54b3SWXtxmA7a8Zp+O44MIUh9vueJv/ekz+7 f6Y1v2lfYogqNXVHZHoDkA== 0000904454-06-000071.txt : 20060126 0000904454-06-000071.hdr.sgml : 20060126 20060126163413 ACCESSION NUMBER: 0000904454-06-000071 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060126 DATE AS OF CHANGE: 20060126 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79927 FILM NUMBER: 06553972 BUSINESS ADDRESS: STREET 1: 43 MOULTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 6174919700 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MVM International Life Sciences Fund No 1 L P CENTRAL INDEX KEY: 0001296587 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 6 HENRIETTA STREET CITY: LONDON STATE: X0 ZIP: WC2E8PIU BUSINESS PHONE: 44-2075577517 MAIL ADDRESS: STREET 1: 6 HENRIETTA STREET CITY: LONDON STATE: X0 ZIP: WC2E8PIU SC 13G/A 1 s13ga_0125-2006.txt MOMENTA AMENDMENT TO SCHEDULE 13G CUSIP No. 60877T 10 1 Page 1 of 8 Pages SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 --------------------- SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILES PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1)[1] Momenta Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.0001 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 60877T 10 1 - -------------------------------------------------------------------------------- December 31, 2005 Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule is Filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ X ] Rule 13d-1(d) - ----------------------- [1]The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 60877T 10 1 Page 2 of 8 Pages - -------------------------------------------------------------------------------- 1) Name of Reporting Person MVM International Life I.R.S. Identification Sciences Fund No. 1, L.P. No. of Above Person (Entities Only) - -------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place United Kingdom of Organization - -------------------------------------------------------------------------------- Number of 5) Sole Voting Shares Beneficially Power -0- Owned by Each Reporting Person With ---------------------------------------------------- 6) Shared Voting 1,610,850 shares Power of Common Stock ---------------------------------------------------- 7) Sole Disposi- tive Power -0- ---------------------------------------------------- 8) Shared Dis- 1,610,850 shares positive Power of Common Stock ---------------------------------------------------- 9) Aggregate Amount Beneficially 1,610,850 shares Owned by Each Reporting person of Common Stock - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares - -------------------------------------------------------------------------------- 11) Percent of Class Represented by 5.3% Amount in Row (9) - -------------------------------------------------------------------------------- 12) Type of Reporting Person PN -2- CUSIP No. 60877T 10 1 Page 3 of 9 Pages - -------------------------------------------------------------------------------- 1) Name of Reporting Person MVM Life Science I.R.S. Identification Partners LLP No. of Above Person (Entities Only) - -------------------------------------------------------------------------------- 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place United Kingdom of Organization - -------------------------------------------------------------------------------- Number of 5) Sole Voting Shares Beneficially Power -0- Owned by Each Reporting Person With ---------------------------------------------------- 6) Shared Voting 8,656 shares Power of Common Stock ---------------------------------------------------- 7) Sole Disposi- tive Power -0- ---------------------------------------------------- 8) Shared Dis- 8,656 shares positive Power of Common Stock ---------------------------------------------------- 9) Aggregate Amount Beneficially 8,656 shares Owned by Each Reporting person of Common Stock - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares - -------------------------------------------------------------------------------- 11) Percent of Class Represented by less than 0.1% Amount in Row (9) - -------------------------------------------------------------------------------- 12) Type of Reporting Person OO -3- CUSIP No. 60877T 10 1 Page 4 of 8 Pages Amendment No. 1 to Schedule 13G --------------------------------- Reference is hereby made to the statement on Schedule 13G originally filed with the Securities and Exchange Commission on January 27, 2005 (the "Schedule 13G".) Terms defined in the Schedule 13G are used herein as so defined. The following Items of the Schedule 13G are hereby amended and restated to read in their entirety as follows: Item 2(a) - Name of Person Filing: MVM International Life Sciences Fund No. 1, L.P. ("MVM Fund No. 1") MVM Life Science Partners LLP ("MVM") Item 4 - Ownership. (a) Amount Beneficially Owned: MVM Fund No. 1: 1,610,850 shares of Common Stock MVM : 8,656 shares of Common Stock (b) Percent of Class: MVM Fund No. 1: 5.3% MVM: less than 0.1% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: -0- (ii) shared power to vote or to direct the vote: MVM Fund No. 1: 1,610,850 shares of Common Stock MVM: 8,656 shares of Common Stock (iii) sole power to dispose or to direct the disposition of: -0- (iv) shared power to dispose or to direct the disposition of: MVM Fund No. 1: 1,610,850 shares of Common Stock MVM: 8,656 shares of Common Stock -4- CUSIP No. 60877T 10 1 Page 5 of 8 Pages Item 8 - Identification and Classification of Members of the Group: See Exhibit 2. -5- CUSIP No. 60877T 10 1 Page 6 of 8 Pages Signature: After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. MVM INTERNATIONAL LIFE SCIENCES FUND NO. 1, L.P. By /s/ Thomas Casdagli --------------------- Director of Finance MVM LIFE SCIENCE PARTNERS LLP By /s/ Thomas Casdagli --------------------- Member Date: January 17, 2006 -6- CUSIP No. 60877T 10 1 Page 7 of 8 Pages EXHIBIT 1 AGREEMENT OF MVM INTERNATIONAL LIFE SCIENCES FUND NO. 1, L.P. AND MVM LIFE SCIENCE PARTNERS LLP PURSUANT TO RULE 13d-1(f) ------------------------------- The undersigned hereby agree that the Information Statement on Schedule 13G to which this Agreement is annexed as Exhibit 1 is filed on behalf of each of them in accordance with provisions of 13d-1(f) under the Securities Exchange Act of 1934, as amended. MVM INTERNATIONAL LIFE SCIENCES FUND NO. 1, L.P. By /s/ Thomas Casdagli --------------------- Director of Finance MVM LIFE SCIENCE PARTNERS LLP By /s/ Thomas Casdagli --------------------- Member Date: January 17, 2006 -7- CUSIP No. 60877T 10 1 Page 8 of 8 Pages EXHIBIT 2 Identification and Classification of Members of the Group ---------------------------------- MVM International Life Sciences Fund No. 1, L.P. and MVM Life Science Partners LLP are filing this statement on Schedule 13G as a group. MVM International Life Sciences Fund No. 1, L.P. is a United Kingdom limited partnership. MVM Life Science Partners LLP is a limited liability partnership organized in the United Kingdom. MVM Life Science Partners LLP is the discretionary investment manager of MVM International Life Sciences Fund No. 1, L.P. -8- -----END PRIVACY-ENHANCED MESSAGE-----